565 related articles for article (PubMed ID: 37803407)
1. Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches.
Hasan N; Nadaf A; Imran M; Jiba U; Sheikh A; Almalki WH; Almujri SS; Mohammed YH; Kesharwani P; Ahmad FJ
Mol Cancer; 2023 Oct; 22(1):168. PubMed ID: 37803407
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in Nanotechnology for the Treatment of Melanoma.
Cassano R; Cuconato M; Calviello G; Serini S; Trombino S
Molecules; 2021 Feb; 26(4):. PubMed ID: 33546290
[TBL] [Abstract][Full Text] [Related]
3. Systemic treatments for metastatic cutaneous melanoma.
Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
[TBL] [Abstract][Full Text] [Related]
4. Advancements in nanoparticle-based treatment approaches for skin cancer therapy.
Zeng L; Gowda BHJ; Ahmed MG; Abourehab MAS; Chen ZS; Zhang C; Li J; Kesharwani P
Mol Cancer; 2023 Jan; 22(1):10. PubMed ID: 36635761
[TBL] [Abstract][Full Text] [Related]
5. Nanotechnology-empowered strategies in treatment of skin cancer.
Chandra J; Hasan N; Nasir N; Wahab S; Thanikachalam PV; Sahebkar A; Ahmad FJ; Kesharwani P
Environ Res; 2023 Oct; 235():116649. PubMed ID: 37451568
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive review on novel targeted therapy methods and nanotechnology-based gene delivery systems in melanoma.
Rahimi A; Esmaeili Y; Dana N; Dabiri A; Rahimmanesh I; Jandaghian S; Vaseghi G; Shariati L; Zarrabi A; Haghjooy Javanmard S; Cordani M
Eur J Pharm Sci; 2023 Aug; 187():106476. PubMed ID: 37236377
[TBL] [Abstract][Full Text] [Related]
7. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
8. Nanotechnology: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
[TBL] [Abstract][Full Text] [Related]
9. Combinatorial approach to treatment of melanoma.
Ashworth MT; Daud AI
Hematol Oncol Clin North Am; 2014 Jun; 28(3):601-12. PubMed ID: 24880950
[TBL] [Abstract][Full Text] [Related]
10. A systematic review of clinical outcomes for patients diagnosed with skin cancer spinal metastases.
Goodwin CR; Sankey EW; Liu A; Elder BD; Kosztowski T; Lo SF; Fisher CG; Clarke MJ; Gokaslan ZL; Sciubba DM
J Neurosurg Spine; 2016 May; 24(5):837-49. PubMed ID: 26544595
[TBL] [Abstract][Full Text] [Related]
11. Targeted cancer therapy; nanotechnology approaches for overcoming drug resistance.
Gao Y; Shen JK; Milane L; Hornicek FJ; Amiji MM; Duan Z
Curr Med Chem; 2015; 22(11):1335-47. PubMed ID: 25666804
[TBL] [Abstract][Full Text] [Related]
12. Cosmeceuticals: Nanotechnology-Based Strategies for the Delivery of Phytocompounds.
Puglia C; Santonocito D
Curr Pharm Des; 2019; 25(21):2314-2322. PubMed ID: 31584366
[TBL] [Abstract][Full Text] [Related]
13. Current Insight into the Therapeutic Potential of Phytocompounds and their Nanoparticle-Based Systems for Effective Management of Lung Cancer.
Fatima M; Iqubal MK; Iqubal A; Kaur H; Gilani SJ; Rahman MH; Ahmadi A; Rizwanullah M
Anticancer Agents Med Chem; 2022; 22(4):668-686. PubMed ID: 34238197
[TBL] [Abstract][Full Text] [Related]
14. Application of nanotechnology in reversing therapeutic resistance and controlling metastasis of colorectal cancer.
Ren SN; Zhang ZY; Guo RJ; Wang DR; Chen FF; Chen XB; Fang XD
World J Gastroenterol; 2023 Apr; 29(13):1911-1941. PubMed ID: 37155531
[TBL] [Abstract][Full Text] [Related]
15. Clinical protein science in translational medicine targeting malignant melanoma.
Gil J; Betancourt LH; Pla I; Sanchez A; Appelqvist R; Miliotis T; Kuras M; Oskolas H; Kim Y; Horvath Z; Eriksson J; Berge E; Burestedt E; Jönsson G; Baldetorp B; Ingvar C; Olsson H; Lundgren L; Horvatovich P; Murillo JR; Sugihara Y; Welinder C; Wieslander E; Lee B; Lindberg H; Pawłowski K; Kwon HJ; Doma V; Timar J; Karpati S; Szasz AM; Németh IB; Nishimura T; Corthals G; Rezeli M; Knudsen B; Malm J; Marko-Varga G
Cell Biol Toxicol; 2019 Aug; 35(4):293-332. PubMed ID: 30900145
[TBL] [Abstract][Full Text] [Related]
16. Recent advancements in immunotherapy of melanoma using nanotechnology-based strategies.
Bahreyni A; Mohamud Y; Luo H
Biomed Pharmacother; 2023 Mar; 159():114243. PubMed ID: 36641926
[TBL] [Abstract][Full Text] [Related]
17. A Comprehensive Review of Various Therapeutic Strategies for the Management of Skin Cancer.
Dachani SR; Kaleem M; Mujtaba MA; Mahajan N; Ali SA; Almutairy AF; Mahmood D; Anwer MK; Ali MD; Kumar S
ACS Omega; 2024 Mar; 9(9):10030-10048. PubMed ID: 38463249
[TBL] [Abstract][Full Text] [Related]
18. Nanotechnology approaches in the current therapy of skin cancer.
Borgheti-Cardoso LN; Viegas JSR; Silvestrini AVP; Caron AL; Praça FG; Kravicz M; Bentley MVLB
Adv Drug Deliv Rev; 2020 Jan; 153():109-136. PubMed ID: 32113956
[TBL] [Abstract][Full Text] [Related]
19. Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy.
Parhi P; Mohanty C; Sahoo SK
Drug Discov Today; 2012 Sep; 17(17-18):1044-52. PubMed ID: 22652342
[TBL] [Abstract][Full Text] [Related]
20. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
